Enhancement of radiotherapy efficacy by docetaxel-loaded gelatinase-stimuli PEG-Pep-PCL nanoparticles in gastric cancer
Enhancement of radiotherapy efficacy by docetaxel-loaded gelatinase-stimuli PEG-Pep-PCL nanoparticles in gastric cancer
复制标题
负载多西紫杉醇的明胶酶刺激 PEG-Pep-PCL 纳米颗粒增强胃癌放疗效果。
DOI:
10.1016/j.canlet.2013.12.002
复制
发表时间:
2014-04-28
期刊:
影响因子:
9.7
通讯作者:
Liu, Bao-Rui
中科院分区:
文献类型:
--
作者:
Cui, Fang-bo;Li, Ru-Tian;Liu, Bao-Rui
Docetaxel (DOC) is widely used as radiosensitizer in various tumors, including gastric cancer (GC), but its therapeutic effect remains to be improved. In this study, using docetaxel-loaded nanoparticles (DOC-NPs) based on gelatinase-stimuli strategy, we compared their radioenhancement efficacy with docetaxel in GC. Compared with DOC, radiosensitization of DOC-NPs was improved significantly (sensitization enhancement ratio increased 1.09-fold to 1.24-fold, P < 0.01) in all three gelatinase overexpressing GC cells, while increased slightly (1.02-fold, P = 0.38) in gelatinase deficient normal gastric mucosa cells. The improved radiosensitization efficacy was associated with enhanced G2/M arrest, increased reactive oxygen species (ROS), more effective DSBs and promoted apoptosis. More importantly, the radiosensitization efficacy of DOC-NPs (estimated as "very active") was more prominent than DOC (estimated as "moderately active") by intravenous injection in xenograft. In conclusion, DOC-NPs are highly selective radiosensitizers in gelatinase over-expressing tumors, and more effective than DOC. By manipulating the common microenvironment difference between tumor and normal tissue, gelatinase-mediated nanoscale delivery system serves as a potential strategy possessing both universality and selectivity for radiosensitizers. (C) 2013 Elsevier Ireland Ltd. All rights reserved.